Repligen Corporation (RGEN) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Repligen shareholders at a glance

The largest holder of Repligen stock is BlackRock Advisors LLC, with 5.7 million shares (10.05% of the company), worth about $671.00 million as of May 18, 2026. The 10 largest holders together own 50.4%.

In Q2 2026, 501 institutional holdings reports listed shares worth $9.07 billion.

Insiders reported 50 transactions in the last two years: 10 sales worth $23.37 million and 2 purchases. The newest one on file is from May 14, 2026 (Mhatre Rohin, Director).

Major holders as of May 18, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 14, 2026.

RGEN logo

Repligen Corporation

RGENUnited States
Healthcare

Shareholders Summary

2026Q2

Filings
501
Options Value
$99.80M
Value (excl. Options)
$9.07B
Shares (excl. Options)
-

Ownership by Type

Geographic Distribution

Largest Repligen shareholders

HolderShares% of companyValue
BlackRock Advisors LLC5.7 million10.05%$671.0M
T. Rowe Price International Ltd.4.9 million8.65%$577.0M
Fidelity Management & Research Co. LLC2.9 million5.12%$341.0M
United Capital Financial Advisors LLC2.8 million4.92%$328.0M
Estate Of Roy T Eddleman2.7 million4.80%$320.0M
Vanguard Capital Management LLC2.4 million4.25%$284.0M
Vanguard Portfolio Management LLC2.3 million4.09%$273.0M
State Street Corporation1.8 million3.15%$210.0M
BNY Mellon Investment Adviser, Inc.1.5 million2.71%$181.0M
Maverick Capital Ltd.1.5 million2.69%$180.0M

As of May 18, 2026.

Repligen institutional holdings by quarter

QuarterReportsSharesValue
Q2 2026501–$9.1B
Q1 202645865.5 million$7.8B
Q4 202549562.5 million$10.2B
Q3 202548560.8 million$8.1B
Q2 202547059.0 million$7.2B
Q1 202546258.1 million$7.4B
Q4 202445456.6 million$8.1B
Q3 202447055.9 million$8.3B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Repligen insider trades

InsiderDateTitleTransactionValue
Mhatre RohinMay 14, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Konstantinov Konstantin BMay 14, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Pax MargaretMay 14, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Madaus Martin D Ph.D.May 14, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Eglinton Manner CarrieMay 14, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Muir Glenn PMay 14, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Dawes Karen AMay 14, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Barthelemy Nicolas MMay 14, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Muir Glenn PMay 7, 2026DirectorConversion of Exercise of derivative security at price 38.76 per share.$94,342
Loeillot OlivierApr 21, 2026Chief Executive OfficerSale at price 140.00 per share.$536,480
Garland Jason K.Mar 5, 2026Chief Financial OfficerStock Award(Grant) at price 0.00 per share.–
Bylund JamesMar 5, 2026Chief Operating OfficerStock Award(Grant) at price 0.00 per share.–

Newest 12 of 50 insider transactions in the last two years.

Questions and answers

Who owns the most Repligen stock?

BlackRock Advisors LLC, with 10.05% of the company (as of May 18, 2026). Next: T. Rowe Price International Ltd. (8.65%) and Fidelity Management & Research Co. LLC (5.12%).

How many institutions own Repligen stock?

501 institutional holdings reports listed Repligen shares in Q2 2026 worth $9.07 billion.

Are Repligen insiders buying or selling the stock?

In the last two years insiders reported 10 sales and 2 purchases (50 transactions in all); the newest on file is from May 14, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube